Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase II OGX-427 trial begins in metastatic prostate cancer

Sep. 30, 2010

Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets

Sep. 30, 2010

Pivotal trial data reported on brentuximab vedotin in Hodgkin's lymphoma

Sep. 29, 2010

NCI selects Bexion to collaborate on cancer nanotherapeutic SapC-DOPS

Sep. 29, 2010

Takeda investigators describe new inhibitors of CDC7-related protein kinase

Sep. 28, 2010

AstraZeneca's phase III zibotentan trial in CRPC does not meet primary endpoint

Sep. 28, 2010

MRC Technology patents novel protein kinase inhibitors

Sep. 28, 2010

CHMP recommends approval of Tasigna in E.U. as first-line therapy for Ph+ CML

Sep. 28, 2010

PLX-4032 shows promise to treat BRAF mutation-positive melanoma

Sep. 28, 2010

NexMed and Bio-Quant present preclinical data on PrevOnco

Sep. 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...